Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Healthcare Regulatory Affairs Outsourcing Market by Type (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, Product Registrations, Regulatory Consulting and Legal Representation, Others), By Application (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage Companies) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Healthcare Regulatory Affairs Outsourcing Market by Type (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, Product Registrations, Regulatory Consulting and Legal Representation, Others), By Application (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage Companies) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 309968 4200 Service & Software 377 152 Pages 4.8 (43)
                                          

Industry Growth Insights published a new data on “Healthcare Regulatory Affairs Outsourcing Market”. The research report is titled “Healthcare Regulatory Affairs Outsourcing Market research by Types (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, Product Registrations, Regulatory Consulting and Legal Representation, Others), By Applications (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage Companies), By Players/Companies PAREXEL, Quintiles IMS, Clinilabs, Accell, Freyr Solutions, Weinberg, Covance, Pharmaceutical Product Development, ICON”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Healthcare Regulatory Affairs Outsourcing Market Research Report

By Type

Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, Product Registrations, Regulatory Consulting and Legal Representation, Others

By Application

Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage Companies

By Companies

PAREXEL, Quintiles IMS, Clinilabs, Accell, Freyr Solutions, Weinberg, Covance, Pharmaceutical Product Development, ICON

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

152

Number of Tables & Figures

107

Customization Available

Yes, the report can be customized as per your need.


Global Healthcare Regulatory Affairs Outsourcing Industry Outlook


Global Healthcare Regulatory Affairs Outsourcing Market Report Segments:

The global Healthcare Regulatory Affairs Outsourcing market is segmented on the basis of:

Types

Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, Product Registrations, Regulatory Consulting and Legal Representation, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage Companies

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. PAREXEL
  2. Quintiles IMS
  3. Clinilabs
  4. Accell
  5. Freyr Solutions
  6. Weinberg
  7. Covance
  8. Pharmaceutical Product Development
  9. ICON

Global Healthcare Regulatory Affairs Outsourcing Market Overview


Highlights of The Healthcare Regulatory Affairs Outsourcing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Regulatory Writing and Publishing
    2. Regulatory Submissions
    3. Clinical Trial Applications
    4. Product Registrations
    5. Regulatory Consulting and Legal Representation
    6. Others
  1. By Application:

    1. Mid-Size Pharmaceutical Companies
    2. Large Pharmaceutical Companies
    3. Biotechnology Companies
    4. Medical Devices Manufacturer
    5. Food & Beverage Companies
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Healthcare Regulatory Affairs Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Healthcare Regulatory Affairs Outsourcing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Healthcare Regulatory Affairs Outsourcing is the process of contracting with a third-party organization to provide regulatory affairs support for a healthcare company. This may include providing advice on compliance with government regulations, developing and managing regulatory submissions, and conducting risk assessments.

Some of the major companies in the healthcare regulatory affairs outsourcing market are PAREXEL, Quintiles IMS, Clinilabs, Accell, Freyr Solutions, Weinberg, Covance, Pharmaceutical Product Development, ICON.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Healthcare Regulatory Affairs Outsourcing Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Healthcare Regulatory Affairs Outsourcing Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Healthcare Regulatory Affairs Outsourcing Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Healthcare Regulatory Affairs Outsourcing Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Healthcare Regulatory Affairs Outsourcing Market Size & Forecast, 2020-2028       4.5.1 Healthcare Regulatory Affairs Outsourcing Market Size and Y-o-Y Growth       4.5.2 Healthcare Regulatory Affairs Outsourcing Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Regulatory Writing and Publishing
      5.2.2 Regulatory Submissions
      5.2.3 Clinical Trial Applications
      5.2.4 Product Registrations
      5.2.5 Regulatory Consulting and Legal Representation
      5.2.6 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Mid-Size Pharmaceutical Companies
      6.2.2 Large Pharmaceutical Companies
      6.2.3 Biotechnology Companies
      6.2.4 Medical Devices Manufacturer
      6.2.5 Food & Beverage Companies
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Healthcare Regulatory Affairs Outsourcing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Regulatory Writing and Publishing
      9.6.2 Regulatory Submissions
      9.6.3 Clinical Trial Applications
      9.6.4 Product Registrations
      9.6.5 Regulatory Consulting and Legal Representation
      9.6.6 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Mid-Size Pharmaceutical Companies
      9.10.2 Large Pharmaceutical Companies
      9.10.3 Biotechnology Companies
      9.10.4 Medical Devices Manufacturer
      9.10.5 Food & Beverage Companies
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Regulatory Writing and Publishing
      10.6.2 Regulatory Submissions
      10.6.3 Clinical Trial Applications
      10.6.4 Product Registrations
      10.6.5 Regulatory Consulting and Legal Representation
      10.6.6 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Mid-Size Pharmaceutical Companies
      10.10.2 Large Pharmaceutical Companies
      10.10.3 Biotechnology Companies
      10.10.4 Medical Devices Manufacturer
      10.10.5 Food & Beverage Companies
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Regulatory Writing and Publishing
      11.6.2 Regulatory Submissions
      11.6.3 Clinical Trial Applications
      11.6.4 Product Registrations
      11.6.5 Regulatory Consulting and Legal Representation
      11.6.6 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Mid-Size Pharmaceutical Companies
      11.10.2 Large Pharmaceutical Companies
      11.10.3 Biotechnology Companies
      11.10.4 Medical Devices Manufacturer
      11.10.5 Food & Beverage Companies
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Regulatory Writing and Publishing
      12.6.2 Regulatory Submissions
      12.6.3 Clinical Trial Applications
      12.6.4 Product Registrations
      12.6.5 Regulatory Consulting and Legal Representation
      12.6.6 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Mid-Size Pharmaceutical Companies
      12.10.2 Large Pharmaceutical Companies
      12.10.3 Biotechnology Companies
      12.10.4 Medical Devices Manufacturer
      12.10.5 Food & Beverage Companies
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Regulatory Writing and Publishing
      13.6.2 Regulatory Submissions
      13.6.3 Clinical Trial Applications
      13.6.4 Product Registrations
      13.6.5 Regulatory Consulting and Legal Representation
      13.6.6 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Mid-Size Pharmaceutical Companies
      13.10.2 Large Pharmaceutical Companies
      13.10.3 Biotechnology Companies
      13.10.4 Medical Devices Manufacturer
      13.10.5 Food & Beverage Companies
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Healthcare Regulatory Affairs Outsourcing Market: Competitive Dashboard
   14.2 Global Healthcare Regulatory Affairs Outsourcing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 PAREXEL
      14.3.2 Quintiles IMS
      14.3.3 Clinilabs
      14.3.4 Accell
      14.3.5 Freyr Solutions
      14.3.6 Weinberg
      14.3.7 Covance
      14.3.8 Pharmaceutical Product Development
      14.3.9 ICON

Our Trusted Clients

Contact Us